ClinicalTrials.Veeva

Menu

Comparisons of the Therapeutic Effects of Dienogest and Danazol on Endometriosis

F

Far Eastern Memorial Hospital

Status and phase

Enrolling
Phase 3

Conditions

Endometriosis

Treatments

Drug: Danazol
Drug: Dienogest

Study type

Interventional

Funder types

Other

Identifiers

NCT05697471
111207-F

Details and patient eligibility

About

The aim of this study is to evaluate the efficacy between dienogest and danazol.

Full description

Objective: Women with adenomyosis or endometripsis are often suffered from dysmenorrhea or menorrhagia. Dienogest and danazol are frequently used for the treatment of endometriosis. However, there was no literature mentioned about which medication is better for the treatment of endometriosis. Thus, the aim of this study is to evaluate the efficacy between dienogest and danazol.

Methods: All consecutive women, who have endometriosis, will be randomized to receive dienogest or danazol treatment, and will assess symptoms severity, receive CA125 examination, sonographic examination at baseline, 4 weeks and 16 weeks after treatment.

Enrollment

120 estimated patients

Sex

Female

Ages

20+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • > 20 years old
  • Have an endometriosis-related condition (including adenomyosis, adenomyoma, ovarian endometrioma, or pelvic endometriosis).

Exclusion criteria

  • Minors.
  • Have a history of breast cancer or other cancers.
  • Patients with vascular obstruction such as stroke.

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

120 participants in 2 patient groups

Dienogest
Experimental group
Treatment:
Drug: Dienogest
Danazol
Active Comparator group
Treatment:
Drug: Danazol

Trial contacts and locations

1

Loading...

Central trial contact

Sheng-Mou Hsiao, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems